Compact 3-channel POCT deployment
Suitable for clinics, emergency settings, smaller labs, and decentralized service points that need practical rapid-testing workflow.
The EXR110 is relevant for institutions comparing small-format POCT systems for rapid workflow, near-patient convenience, and basic immunofluorescence deployment.
The EXR110 is relevant for institutions comparing small-format POCT systems for rapid workflow, near-patient convenience, and basic immunofluorescence deployment.
ZYBIO EXR110 POCT analyzer in Ethiopia for compact 3-channel immunofluorescence testing with 3-15 minute result workflow and near-patient deployment.
Suitable for clinics, emergency settings, smaller labs, and decentralized service points that need practical rapid-testing workflow.
Relevant where speed, decentralized placement, and manageable operation matter more than large centralized workflow.
Provides a clear entry point into Berhan Pharma POCT family for smaller institutions and phased procurement.
Key reasons this family matters during procurement, deployment planning, and technical review.
Helps buyers evaluate rapid testing around use context rather than mixing it with centralized laboratory systems.
Gives the product page concrete procurement detail instead of generic compact-device positioning.
Separates rapid immunofluorescence workflow from CLIA and routine chemistry categories.
Final value depends on required analytes, reagent availability, sample type, and reporting needs.
Quick comparison points used during technical review, model shortlisting, and quotation alignment.
Compact EXR family testing class.
Typical EXR family rapid-result positioning; assay timing depends on test item.
Sample type depends on assay and local reagent configuration.
Best evaluated against specific analyte menu and workflow need.
How institutions usually frame this product family during department-level planning and quotation review.
Suitable for environments where turnaround time and practical deployment matter most.
Useful where testing needs to move closer to the patient rather than staying fully centralized.
Supports buyers comparing compact rapid-testing platforms.
Cross-links inside the product family for faster comparison and navigation.